BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes ...

The announcement could shake up the market for such injections, since the shortage designation allowed compounding pharmacies ...

Arrowhead's plozasiran shows promising Phase 3 data for FCS, with potential blockbuster status, but faces competition. Learn ...

But regardless of what patients take them for, there is an outstanding concern: the muscle loss that often accompanies rapid ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

A study from tirzepatide's manufacturer found that the GLP-1 drug could significantly improve heart failure symptoms.

Terns Pharma is in the process of developing TERN-601 for the treatment of patients with obesity. See why I rate TERN stock ...

There are several Ozempic alternatives available today, like Rybelsus, Mounjaro, Wegovy and Zepbound. Other medications may ...

Weight loss injections are medications that help the user lose weight. These drugs have been increasing in popularity over ...

Amid a flurry of weight loss readouts, a fresh-on-the-scene startup has come out with Phase I results showing weight loss at day 36 on par with or better than competitors, with few gastrointestinal ...